Al­go­Ther­a­peu­tix’s top­i­cal non-opi­oid drug has flunked a mid-stage tri­al in chemother­a­py-in­duced pain due to a stronger-than-ex­pect­ed place­bo arm, but the com­pa­n ...

s USA subsidiary, Thursday announced the launch of Clindamycin Phosphate Foam, 1 percent for the treatment of acne. The company added that Clindamycin Phosphate Foam, 1 percent is bioequivalent ...

1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the property of their respective owners.

QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced Sucraid® (sacrosidase) Oral Solution has been shown to be 81% effective in treating patients with Congenital ...

1 Glenmark’s Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark’s approved label. 2 All brand names and trademarks are the property of their respective owners. 3 ...

Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically equivalent to Evoclin® ...

When is the Ark 2 release date? Ever since the Ark 2 announcement at The Game Awards 2020, we’ve been looking forward to learning more about the upcoming dinosaur-themed survival game.

The “Clindamycin Phosphate Topical Market” report delivers a comprehensive analysis of the industry, providing valuable insights into its SWOT analysis, growth prospects, and anticipated CAGR.

Sens. Josh Hawley (R-Mo.) and Bernie Sanders (I-Vt.) introduced a bill Tuesday seeking to cap credit card interest rates at 10 percent. “Credit card interest rates are out of control.